chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I got dizzy right after the vaccine. My arm was sore the rest of the afternoon. At night I started getting spasms in my abs and back. I became disoriented and my toes were moving on their own. It lasted about 30 min at 3:30 am. The next morning I went out for a run and got dizzy at the end of my run. That same night, last night I got the same spasms randomly during the night.
Loss of appetite with no urge to eat. Only drank fluids. Problems with thinking and judgement. Panic attack, lack of mental clarity and lack of ability to focus on more than one task everyday after receiving the second dose of the vaccine.
The patient was seen in the office today because she thinks she might of had a reaction to a pneumococcal vaccine. She got her PCV 20 on April 26. Yesterday she started noticing a redness and itching of the left arm. She took some Benadryl but today the symptoms were worse. She has no idea how long she had the rash. She first noticed it yesterday. She states she does have a history of having reactions to her allergy shots in the past. She has not had any fever or chills
10/14/2022 I had been dealing with allergies, sneezing and coughing. I took ZYRTEC. Later in the day, I started feeling trashing, around 2. I began having a headache and fever. That evening my fever was 100.7. I took TYLENOL. On 10/16/2022 I was coughing your head off, wheezing and constant sneezing. On 10/17/2022 I took a home COVID test which was positive, and I called my physician's office and reported the positive COVID test. They told me to not go to work and stay quarantine for 5 days. The nurse practitioner did a tele health with me. I was prescribed PAXLOVID and began taking it that evening. I did not notice anything until Day 2 or Day 3 when I started feeling better. I continued treating the fever with TYLENOL which went down. Day 2 on PAXLOVID my symptoms began to subside and I began feeling better. Day 3 on PAXLOVID, I felt my normal self. Day 5 on PAXLOVID, I tested negative for COVID.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. On an unknown date the patient was vaccinated with liquid PEDVAXHIB (lot #, expiration date, route, dose and frequency unknown). On unknown dates the patient inadvertently received liquid PEDVAXHIB at 2, 4, and 6 months. No adverse effects were reported. Additional information has been requested.
Extreme soreness in arm after COVID vaccine; This is a spontaneous report from a non-contactable consumer or other non-healthcare professional (patient) via Pfizer sales representative.   A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced extreme soreness in arm after COVID vaccine. The event was occurred after use of product. The outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Fever 100.4-101 >48 hours Headache Chills, Muscle aches Ipsilateral to vaccine site Lymphadenopathy- axillary, breast, supraclavicular >48 hours Axillary swelling and tenderness Breast tenderness
I started having a headache on 04/03/2021 that wouldn't go away.  I checked my blood pressure on 04/06/2021 and it was elevated at 190/100.  It stayed elevated for the next few days.  I went to a care center on 04/09/2021 and started on Amlodipine 5mg until I could see my primary Dr. a couple days later.  He added Losartan 25mg which I am still taking both.  I have never had an elevated blood pressure.
Initial report received from a physician on 31 August 2007. A 59 year old, female patient (with a history of chemical sensitivities), felt as if her "ears were plugged up" and had a "bad taste in her mouth", immediately after she received 2 shots of IMOVAX (lot number not reported) in the right and left deltoids on 21 August 2007. She had rabies post exposure series in the past. A second exposure occurred and she was seen in the hospital. A few days later, she began having a severe headache in the frontal/temporal area. She experienced the same symptoms as when she is exposed to substances such as pesticides. At the time of the report, she had not recovered.
Information has been received from a physician concerning a female who on an unspecified date was vaccinated intramuscularly with a 0.5 ml dose of GARDASIL. On the same office visit as vaccination, the patient had syncope after getting GARDASIL. In the office that day, the patient recovered from syncope. The patient saw the doctor and sought unspecified medical attention. This is one of several reports received from the same source. Additional information has been requested.
Pain anterior to injection site, difficult lifting arm and, red splotches approximately 6 inches X 3 inches.
I was given the SHINGRIX vaccine at around 11:00 a.m. on January 16, 2018. A couple of hours later, my right arm became sore at the injection site and following down my right arm. At about 9:00 p.m. on the same date, I started to have flu-like symptoms. My fever rose to 101 degrees F, and I became very shaky. I had difficulty sleeping and I finally got out of bed around 11:00 a.m. the next morning (01/17/2018). I still have a slightly elevated temperature level (100.3), but I feel better--if not very drained. I called the pharmacy and spoke with the pharmacist who was filling in for the day. He was not the administrator of the shot. However, he was helpful in describing some possible side effects although he did not think my condition arose from the vaccination, but rather the current flu that is quickly traveling around the country. I countered his comments with the observation that I thought it was an unlikely coincidence that I had flu-like symptoms after receiving the vaccination.
Pain in the injection site (lasted 3 days) muscle pain in buttocks (lasted 3 days). Found relief with Tylenol
After receiving first dose of Pfizer COVID-19 vaccination, patient reported feeling itching along her neck, back, and head. Patient was given 25 mg Benadryl and watched for additional time. Patient stated that her symptoms had resolved and she was discharged home in stable condition.
Information regarding Flumist was received from a physician regarding his 44 year old wife who developed flu-like symptoms, nausea, stiffness, chills, low grade fever, laryngitis and cough following vaccine administration on 11/27/03. On 11/29/03, she developed flu-like symptoms characterized by nausea, stiffness (musculoskeletal stiffness), chills and low grade fever. On 12/3/03, she developed laryngitis. As of 12/4/03, the laryngitis, cough, and "mild bronchitis symptoms" persisted. No additional info was available at the time of this report.
Within 12 hours of 2nd injection woke up at 4:30 am feeling nauceious, diarharra, body aches terrible in back. (Advil taken after piece of peanut butter toast ingested) By Noon: headaching was beginning to set in.  Body aches still terrible in back. (took Advil at noon for headache and body aches, ate small bowl of chicken noodle soup with ginger ale) By 4:00 pm: vominting every hour on the hour til 10:00pm.  Headached is dilibating: have to be laying in bed with arm over head and eyes closed. Got to sleep that night after 10:00 vomiting spell.  Slept through night. Monday morning dull headache behind right temple.  Toast and Advil taken. Body aches in back still present but less severe.  Took Advil every 4 hours for the day to keep headache under control and rested a bit from fatigue.  Monday, April 26 notice bumps forming on my right side under my arm pit.  Notice about 2 -4 bumps at that time. Stomach is growly, loud, rolls, random waves of nausesousness.  Loose bowl at aprox 4:00pm daily for the week (not normal/typcial), right leg begins to have noticalbe times when it tingles like my leg is falling asleep while sstanding at work or walking.  Approx. 4-6 spells of that throughout the day.  Tuesday & Wednesday, April 27th and 28th, expericce break through bleeding (spotting, never had this occur before and on birthcontrol pill.) During this time, the bumps are multiplying down right side of back.  Approx, 15, then 25, then by Friday when visted doctor approxiamtely 35-50 bumps/rash on side/back.  mostly on the right side, but a few are scattered on left side.   Dull headache was expereicned each morning during this week.  Advil was taken with morning pill/vitamins to treat headache.  Throughout all of this NEVER expereiced a fever.
High fever developed (103 degrees F), with extreme fussiness and irritability; this continued for 5 days, then a rash developed on his torso. Fever continued, other symptoms indicative of Kawasaki Disease appeared. Diagnosed with Kawasaki's Disease. He was admitted to the hospital and received IVIG and high dose ASA. Hospitalization lasted 3 days. We are following up with echocardiogram's which showed an ectasia of the left coronary artery.
Light headed, Subconscious B/P: 120/76, 40, 86
Right glutteal region red, tender, and warm.  Treated with Keflex for 7 days, Benadryl.  Ambulating without difficulty.
8 days post vax, the pt developed cellulitis at the injection site. A doctors visit was required. Starting on 8/2/00 the pt was treated with ceftriaxone sodium (Rocephin). The cellulitis resolved on 8/12/00. The physician believed it was related to the injection and not to the vaccine. The adverse event was considered to be mild in intensity. As of 11/10/00, the outcome of the event is resolved.
Pt received Shingrix dose on 12/2/19 at approx. 7pm.  Pt developed extreme weakness and could not stand by 12noon on 12/3/19.  Pt was transported by ambulance to local hospital and presented with extreme weakness, inability to stand, 101 degree fever, chills, and headache.  Tests were done, with no other obvious explanation for symptoms. As of this morning, lab values had not been returned yet, everything on heart monitor is O.K., his blood pressure is within a normal range.  The hospitalist is running cultures to attempt to identify any other possible infectious source.  Pt. is still in observation unit of hospital, but is much improved, is able to walk, but headache still remains.  Pt's PCP told pt that a small number of patients react negatively to Shingrix.  All this info was relayed to me by pt's wife, on 12/4/19 at about 08:30 am.
This case was reported by a consumer (the company owner) and described the occurrence of injection site redness in a subject of unspecified age and gender who was vaccinated with FLULAVAL (GlaxoSmithKline). A physician or other health care professional has not verified this report. On an unspecified date the subject received a dose of FLULAVAL (details unknown). At an unspecified time after vaccination with FLULAVAL, the subject experienced injection site redness. At the time of reporting the outcome of the event was unspecified. The consumer reported that 5 employees at one company and one employee at another company all reported extreme redness at the injection site after receiving FLULAVAL. This is case 4 of 6 (see case IDs A0952647A, A0952653A, A0952654A, A0952656A, A0952657A for details of the other reports).
Left eye swelling with red streak from eye down to cheek. A bit redder this morning on 12/30/2015.
Erythromelalgia; 3/19/2021 Patient is a 76-year-old female who presents to the emergency department for evaluation of a pruritic rash. Is been present for just over 1 month. She relates that began after receiving her second Covid vaccination. She denies any new exposures medicines foods cleaning items or hygiene supplies. She denies any systemic symptoms. No airway symptoms. Physical exam significant for dry erythematous rash. Is suggestive of eczema. His primary to the right hand in the palm. It seems to spare the dorsum of the hand. There is diffuse swelling. No fissures or lesions. No evidence of secondary infection.
COVID-19 Treatment; COVID-19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 34-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 03Mar2021 as dose 1, single (Batch/Lot number: unknown), on 24Mar2021 as dose 2, single (Batch/Lot number: unknown) and on 12Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 34 years for covid-19 immunisation. The patient's relevant medical history included: "Bipolar disorder" (unspecified if ongoing); "Arthritis" (unspecified if ongoing); "Ovarian cyst" (unspecified if ongoing); "known allergies: dust" (unspecified if ongoing); "known allergies: pollen" (unspecified if ongoing). Concomitant medication(s) included: LITHIUM CARBONATE; ABILIFY; LAMOTRIGINE. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID-19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (07May2022) Negative, notes: Post-paxlovid series I tested negative on an antigen test on 07May; (unspecified date) Positive, notes: Treatment of COVID-19; (10May2022) Negative, notes: and then negative on a PCR on 10May; (18May2022) Positive, notes: On 18May I tested positive on 2 rapid tests; (18May2022) Positive, notes: On 18May I tested positive on 2 rapid tests; (19May2022) Positive, notes: and then positive again on 19May on a rapid test. Therapeutic measures were taken as a result of vaccination failure, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Numbness of entire arm within 15 minutes of vaccination, shoulder to fingertips. Numbness remained for over 24 hours. First 48 hours, fever, chills, body aches, headache, debilitating fatigue After 24 hours, increasing mild Bell?s palsy facial tingling and numbness. Some difficulty speaking for 24 hours. Mild Bell's palsy for two full weeks without cessation, concentrated in the right side of face. In third week, less frequent, but still present.
This spontaneous report as received from a physician refers to a 62 year old female patient. Her pertinent medical history included hypothyroidism and gastritis. She was allergic to cholestatin. On 01-AUG-2016, the patient was vaccinated with ZOSTAVAX (dose not reported) lot # L032184, subcutaneous. Concomitant therapies included SYNTHROID and ZANTAC. On 01-AUG-2016, the patient experienced myalgia and muscle pain. The patient sought medical attention. Treatment was given for the event (details were not reported). It was reported that the patient still has symptoms since the injection. The causal relationship between the event and the drug was not reported. There was no product quality complaint (PQC) involved. Additional information has been requested.
Immediately after I got the shot, my period started in full force, 8 days early, instantly.  I mean it was 10 mins after the shot and the cramps started so Ihurried home so I could clean myself up. It only lasted 2-3 days, and then I still had my regular period occur on time and like normal.
Patient received two vaccines in right arm intramuscular injections on 2/22/18. By the end of the evening mother had noticed swelling and redness around the injection site. States the size of a quarter. By morning patient had complained of pain in right area where injection site is. Mother then noticed the redness, warmth, and swelling spreading to a larger area about the size of an orange. She contacted patients primary care physician and has an appointment scheduled so we could better evaluate the patient. As patient was being seen in the office it was determined that the patient had an adverse event to the vaccines given. Dr ordered 8 mg of DECADRON to be administered intramuscularly in the patients left thigh. She also prescribed hydroxyzine 10 mg to be taken by mouth every 8 hours for four days and prednisone 20 mg and patient is to take 1.5 tablets by mouth twice a day for three days. A recheck has also been scheduled so we may closely monitor this patient.
Approximately 9 days after I had my Johnson & Johnson vaccine I started experiencing Guillian Barre type  symptoms. After my vaccination the symptoms I got were weakness in my legs and some tingling. As well as some generalized weakness. It definitely felt similar to the onset of Guillain-Barre when I had it but nowhere near the intensity. I would say these symptoms were a one on a scale of 1 to 10. But after having Guillain-Barre even though that was 43 years ago you don't forget anything. I remember it as if it was yesterday. I didn't think much about reporting it until recently when others were experiencing Gillian Barre after the Johnson & Johnson vaccine. The following gives you a brief synopsis of how my particular case when I was 16 ran  it's course. I hope this helps with research as well as to help others.   I had Guillian Barre when I was 16 years old.  It presented with weakness in my legs and feet, and progressed with numbness. They said it was a classic case. I was admitted to the ICU approximately 3 days after symptoms began. When I was admitted, I could still walk, within 48 Hours it had progressed to everything except for my respiratory system. It ascended and descended with Laundry's paralysis. My CSF protein was elevated significantly. I don't recall them sharing any other clinical markers other than the CSF protein .
Information has been received from a physician concerning a 15 month old male with no known history or allergies who in approximately May 2002, was vaccinated SC with a dose of MMR II. There were no concomitant vaccinations or other concomitant therapy. Shortly after administration, the patient developed a high temperature and approximately 7-10 days later had a seizure. Additional information from the physician indicated that the patient experienced a febrile seizure post vaccination. The patient recovered shortly after the event. Unspecified medical attention was sought. There was no product quality complaint involved. Upon internal review the febrile seizure was determined to be an other important medical event. Additional information has been requested.
Four patients were given the second dose on Tuesday morning between 15hour and 18hour period.; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Four patients were given the second dose on Tuesday morning between 15hour and 18hour period.) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jun-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Four patients were given the second dose on Tuesday morning between 15hour and 18hour period.). On 15-Jun-2021, EXPIRED PRODUCT ADMINISTERED (Four patients were given the second dose on Tuesday morning between 15hour and 18hour period.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Extreme weakness in right knee; It would not hold me and I was unable to walk on it. If I tried to walk, it would give out and I would almost fall; It would not hold me and I was unable to walk on it. If I tried to walk, it would give out and I would almost fall; This is a spontaneous report from a non-contactable consumer, the patient. A 29-year-old patient of an unknown gender received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the right arm on 11Apr2021 at 14:15 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included migraines. Prior to vaccination, the patient was not diagnosed with COVID -19. The patient had no known allergies to medications, food or other products. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER6955) via an unspecified route of administration in the right arm on 21Mar2021 at 14:15 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021 at 23:30, the patient experienced extreme weakness in right knee and it would not hold the patient and the patient was unable to walk on it and even if the patient tried to walk, it would gave out and the patient would almost fall. It lasted about 30-40 minutes and then went away. On 12Apr2021, the patient underwent nasal swab test and the result was negative. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the events extreme weakness in right knee, unable to walk on it and tried to walk, it would gave out and would almost fall was recovered on 12Apr2021.  No follow-up attempts are possible. No further information is expected.
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a currently 69 year old female patient. No information was provided regarding medical history, concurrent conditions, or concomitant medications.   On an unknown date in 2016, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, dose# and route not specified) for the long-term prevention of shingles and zoster-related conditions.   On an unspecified date, the patient experienced shingles. On an unspecified date, the patient was treated by a physician for shingles. The outcome of the event was not reported. The reporter considered the event to be related to zoster vaccine live (ZOSTAVAX).
Dizziness, headaches, and nausea since the day after first vaccination. I have felt light headed/dizzy or off balance, daily since vaccination. It comes and goes throughout the day.
24 hrs after vaccines given patient came back to office with, redness, swelling, itchy & sore to touch (L) arm upper wheal 30 x 20 mm & (L) arm lower wheal 10 x 12 mm. 48 hrs from IZ L upper 40x60mm - used benadryl & IBU
This spontaneous report was received from a registered nurse referring to an unspecified patient of unknown age and gender. Information about the patient's medical history and concurrent conditions was not provided. On 07-JAN-2016, the patient was vaccinated with improperly stored doses of (Oka/Merck) VARIVAX lot # L024252, 30-JUN-2017 and M-M-R II rHa, lot #: L024267, expiration date: 01-JUL-2017 (administration routes were not provided). No concomitant therapies were reported, neither was any adverse effect. It was unknown if the patient sought medical attention. No product quality complaint was involved. This is one of two reports from the same reporter. Additional information has been requested.
Red, non tender patch of about 6 cm x 2 cm. No evidence of systemic reaction or cellulitis.
Beginning 24 hours after the vaccines, the patient began throwing up once a day for 5 days.  He was fussy and distraught especially two days after the vaccines.  He had a low appetite and was not himself.  He also had 4 diapers of diarrhea.    He did not have a fever or difficulty sleeping thankfully.